These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. PRO 2000 gel inhibits HIV and herpes simplex virus infection following vaginal application: a double-blind placebo-controlled trial. Keller MJ; Zerhouni-Layachi B; Cheshenko N; John M; Hogarty K; Kasowitz A; Goldberg CL; Wallenstein S; Profy AT; Klotman ME; Herold BC J Infect Dis; 2006 Jan; 193(1):27-35. PubMed ID: 16323128 [TBL] [Abstract][Full Text] [Related]
3. A comprehensive murine model to evaluate topical vaginal microbicides: mucosal inflammation and susceptibility to genital herpes as surrogate markers of safety. Galen BT; Martin AP; Hazrati E; Garin A; Guzman E; Wilson SS; Porter DD; Lira SA; Keller MJ; Herold BC J Infect Dis; 2007 May; 195(9):1332-9. PubMed ID: 17397004 [TBL] [Abstract][Full Text] [Related]
4. Assessment of cervicovaginal cytokine levels following exposure to microbicide Nisin gel in rabbits. Aranha CC; Gupta SM; Reddy KV Cytokine; 2008 Jul; 43(1):63-70. PubMed ID: 18513989 [TBL] [Abstract][Full Text] [Related]
5. Safety, tolerability, and systemic absorption of dapivirine vaginal microbicide gel in healthy, HIV-negative women. Nel AM; Coplan P; van de Wijgert JH; Kapiga SH; von Mollendorf C; Geubbels E; Vyankandondera J; Rees HV; Masenga G; Kiwelu I; Moyes J; Smythe SC AIDS; 2009 Jul; 23(12):1531-8. PubMed ID: 19550287 [TBL] [Abstract][Full Text] [Related]
6. The topical microbicide PRO 2000 protects against genital herpes infection in a mouse model. Bourne N; Bernstein DI; Ireland J; Sonderfan AJ; Profy AT; Stanberry LR J Infect Dis; 1999 Jul; 180(1):203-5. PubMed ID: 10353881 [TBL] [Abstract][Full Text] [Related]
7. ACIDFORM inactivates herpes simplex virus and prevents genital herpes in a mouse model: optimal candidate for microbicide combinations. Tuyama AC; Cheshenko N; Carlucci MJ; Li JH; Goldberg CL; Waller DP; Anderson RA; Profy AT; Klotman ME; Keller MJ; Herold BC J Infect Dis; 2006 Sep; 194(6):795-803. PubMed ID: 16941346 [TBL] [Abstract][Full Text] [Related]
8. Fourteen-day safety and acceptability study of 6% cellulose sulfate gel: a randomized double-blind Phase I safety study. Schwartz JL; Mauck C; Lai JJ; Creinin MD; Brache V; Ballagh SA; Weiner DH; Hillier SL; Fichorova RN; Callahan M Contraception; 2006 Aug; 74(2):133-40. PubMed ID: 16860051 [TBL] [Abstract][Full Text] [Related]
9. The molecular basis of nonoxynol-9-induced vaginal inflammation and its possible relevance to human immunodeficiency virus type 1 transmission. Fichorova RN; Tucker LD; Anderson DJ J Infect Dis; 2001 Aug; 184(4):418-28. PubMed ID: 11471099 [TBL] [Abstract][Full Text] [Related]
10. Phase I randomized safety study of twice daily dosing of acidform vaginal gel: candidate antimicrobial contraceptive. Keller MJ; Carpenter CA; Lo Y; Einstein MH; Liu C; Fredricks DN; Herold BC PLoS One; 2012; 7(10):e46901. PubMed ID: 23056520 [TBL] [Abstract][Full Text] [Related]
11. Starting to gel. Pilcher H Nature; 2004 Jul; 430(6996):138-40. PubMed ID: 15241385 [No Abstract] [Full Text] [Related]
12. Vaginal microbicides. O'Brien RF Adolesc Med Clin; 2006 Oct; 17(3):673-85; abstract xi. PubMed ID: 17030285 [TBL] [Abstract][Full Text] [Related]
13. Antimicrobial polypeptides are key anti-HIV-1 effector molecules of cervicovaginal host defense. Cole AM; Cole AL Am J Reprod Immunol; 2008 Jan; 59(1):27-34. PubMed ID: 18154593 [TBL] [Abstract][Full Text] [Related]
14. A phase I study of a novel potential intravaginal microbicide, PRO 2000, in healthy sexually inactive women. Van Damme L; Wright A; Depraetere K; Rosenstein I; Vandersmissen V; Poulter L; McKinlay M; Van Dyck E; Weber J; Profy A; Laga M; Kitchen V Sex Transm Infect; 2000 Apr; 76(2):126-30. PubMed ID: 10858715 [TBL] [Abstract][Full Text] [Related]
15. Efficacy of an acidic vaginal gel on vaginal pH and interleukin-6 levels in low-risk pregnant women: a double-blind, randomized placebo-controlled trial. Paternoster DM; Tudor L; Milani M; Maggino T; Ambrosini A J Matern Fetal Neonatal Med; 2004 Mar; 15(3):198-201. PubMed ID: 15280147 [TBL] [Abstract][Full Text] [Related]
16. Amphipathic DNA polymers are candidate vaginal microbicides and block herpes simplex virus binding, entry and viral gene expression. Guzman EM; Cheshenko N; Shende V; Keller MJ; Goyette N; Juteau JM; Boivin G; Vaillant A; Herold BC Antivir Ther; 2007; 12(8):1147-56. PubMed ID: 18240855 [TBL] [Abstract][Full Text] [Related]
17. PRO-2000, an antimicrobial gel for the potential prevention of HIV infection. Fletcher PS; Shattock RJ Curr Opin Investig Drugs; 2008 Feb; 9(2):189-200. PubMed ID: 18246522 [TBL] [Abstract][Full Text] [Related]
18. Safety and acceptability of cellulose sulfate as a vaginal microbicide in HIV-infected women. El-Sadr WM; Mayer KH; Maslankowski L; Hoesley C; Justman J; Gai F; Mauck C; Absalon J; Morrow K; Mâsse B; Soto-Torres L; Kwiecien A AIDS; 2006 May; 20(8):1109-16. PubMed ID: 16691061 [TBL] [Abstract][Full Text] [Related]
19. Interleukin (IL)-1, IL-6, and IL-8 predict mucosal toxicity of vaginal microbicidal contraceptives. Fichorova RN; Bajpai M; Chandra N; Hsiu JG; Spangler M; Ratnam V; Doncel GF Biol Reprod; 2004 Sep; 71(3):761-9. PubMed ID: 15128598 [TBL] [Abstract][Full Text] [Related]